Study shows novel mass screening method could slash COVID-19 testing costs
The hypercube algorithm aims to enable regular, cost-effective screening in multiple contexts
The hypercube algorithm aims to enable regular, cost-effective screening in multiple contexts
Learn the importance of low LoD tests and discover the most sensitive kits available, as determined by the FDA’s SARS-CoV-2 Reference Panel
Find out how Zymo Research’s state-of-the-art tools are helping laboratories and government agencies facilitate large-scale COVID-19 testing in the United States
Experts share novel techniques for accelerating monoclonal antibody discovery and development to bring hope to COVID-19 patients
Watch this webinar on demand to learn about the host immune response to COVID-19
The test uses a convolutional neural network to classify microscopy images of single intact particles of different viruses
In combination with other COVID-19 diagnostic tests, the Elecsys SARS-CoV-2 Antigen test can help in the management of patients for optimal care delivery
Availability of the new IgM blood test on the ARCHITECT and Alinity platforms is part of Abbott's effort to offer tests across the disease progression of COVID-19
The CTS Rotea system aims to help researchers overcome manufacturing hurdles and bring the vast potential of cell therapies to more patients
Find out how experts at the Ellison Institute are harnessing new cell monitoring technology to build cancer cell biobanks and enhance cell line quality control and authentication
Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies
Summa Equity Fund II acquires a majority stake in Sengenics, a functional proteomics company with a unique technology for production of full-length, correctly folded and functional proteins
Antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein
The CleanPlex ACE2 & TMPRSS2 Panel assesses differences in patients’ genetic susceptibility to COVID-19 infection and to developing severe disease
Find out how to rapidly test for multiple disease-causing microorganisms with syndromic panel-based testing
Join us on Wednesday, October 28, to learn how SpyTag-SpyCatcher technology enables site-directed conjugation and rapid assembly of different antibody format
Combination test for COVID-19, flu and other common respiratory illnesses helps health care professionals prepare for flu season
The addition of COVID-19 antibody tests to the portfolio aims to further support the pandemic response on multiple fronts
Learn how high-throughput, real-time cell analysis can accurately detect and quantify virus-neutralizing antibodies and see how this technology is advancing COVID-19 research